Entity Details

Primary name PLOD2_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionO00469
EntryNamePLOD2_HUMAN
FullNameProcollagen-lysine,2-oxoglutarate 5-dioxygenase 2
TaxID9606
Evidenceevidence at protein level
Length737
SequenceStatuscomplete
DateCreated1998-12-15
DateModified2021-06-02

Ontological Relatives

GenesPLOD2

GO terms

Show/Hide Table
GOName
GO:0001666 response to hypoxia
GO:0005506 iron ion binding
GO:0005783 endoplasmic reticulum
GO:0005789 endoplasmic reticulum membrane
GO:0006464 cellular protein modification process
GO:0008475 procollagen-lysine 5-dioxygenase activity
GO:0017185 peptidyl-lysine hydroxylation
GO:0030199 collagen fibril organization
GO:0030867 rough endoplasmic reticulum membrane
GO:0031418 L-ascorbic acid binding
GO:0046947 hydroxylysine biosynthetic process
GO:0070062 extracellular exosome

Subcellular Location

Show/Hide Table
Subcellular Location
Rough endoplasmic reticulum membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR001006 Procollagen-lysine 5-dioxygenase, conserved siteSiteConserved site
IPR005123 Oxoglutarate/iron-dependent dioxygenaseDomainDomain
IPR006620 Prolyl 4-hydroxylase, alpha subunitDomainDomain
IPR029044 Nucleotide-diphospho-sugar transferasesFamilyHomologous superfamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
609220 OMIMBruck syndrome 2 (BRKS2)An autosomal recessive disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia. It is distinguished from osteogenesis imperfecta by the absence of hearing loss and dentinogenesis imperfecta, and by the presence of clubfoot and congenital joint limitations. The disease is caused by variants affecting the gene represented in this entry. The molecular defect leading to Bruck syndrome is an aberrant cross-linking of bone collagen, due to underhydroxylation of lysine residues within the telopeptides of type I collagen, whereas the lysine residues in the triple helix are normal.

Drugs

Show/Hide Table
DrugNameSourceType
DB00126 Ascorbic acidDrugbanksmall molecule